IO Biotech to participate in panel discussion at BIO-Europe Spring in Amsterdam on March 12, 2018
Copenhagen, Denmark – February 20, 2018: IO Biotech’s CEO, Mai-Britt Zocca, is to participate in the panel discussion “The Harrods Food Hall problem in immuno-oncology” at the partnering conference BIO-Europe Spring in Amsterdam on March 12, 2018.
The subject for discussion is based on the many promising options with immuno-oncology, which continue to be at the forefront of efforts to improve outcomes in cancer. The panel will provide some vision into the future of this complex and dynamic space and will highlight key themes that may show where the next wave of innovation may come and where there may be white space in the biology, and, importantly, opportunities for investment in clinical development as well as what biopharma will be looking for from Immuno-oncology-centric newcos.
IO Biotech will participate in the discussion together with MSD, Janssen and Forbion, and the discussion will be moderated by Defined Health.
Please find the description of the panel discussion here: The Harrods Food Hall problem in immuno-oncology
The discussion is to take place at March 12th from 17:15-18:15 in room E107/108 at the RAI Amsterdam Convention Centre.